
LFPI does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for LFPI and 80,000+ other tickers.
See exactly how LFPI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LFPI and 80,000+ other tickers.
LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical services (ambulances), retail pharmacies, public safety organizations, and the home healthcare sector. Established in 1992, the company was formerly known as US Drug Testing, Inc. until it adopted its current name, LifePoint, Inc., in February 1998. Its headquarters are situated in Ontario, California.
No recent news available.